RecruitingNCT06838611

ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation


Sponsor

Medical University of Warsaw

Enrollment

300 participants

Start Date

Nov 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry study collects data from patients with severe tricuspid regurgitation — a heart valve problem where the tricuspid valve leaks blood backwards — who are being treated with a minimally invasive (catheter-based) procedure instead of open-heart surgery. The goal is to understand real-world outcomes of this approach. **You may be eligible if...** - You have been diagnosed with tricuspid regurgitation - You have been approved for a catheter-based (transcatheter) tricuspid valve procedure - You are willing to be entered into the registry **You may NOT be eligible if...** - Your tricuspid regurgitation requires open-heart surgery - You also have a left-sided heart valve problem that requires surgery - You have multi-vessel coronary artery disease requiring bypass surgery - You do not consent to being in the registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscatheter edge-to-edge repair

Transcatheter edge-to-edge repair of the tricuspid valve for the treatment of severe tricuspid valve regurgitation.


Locations(1)

First Department of Cardiology, Medical University of Warsaw

Warsaw, Masovian Voivodeship, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06838611


Related Trials